UB-VV410
/ Umoja Biopharma, IASO BIO
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 24, 2026
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
(clinicaltrials.gov)
- P1 | N=21 | Recruiting | Sponsor: Nanjing IASO Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
August 08, 2025
UB-VV410 in Subjects With Active Refractory Systemic Lupus Erythematosus or Lupus Nephritis
(clinicaltrials.gov)
- P1 | N=21 | Not yet recruiting | Sponsor: Nanjing IASO Biotechnology Co., Ltd.
New P1 trial • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus
1 to 2
Of
2
Go to page
1